- Call now
- Send an email
- Leave a review
- Bookmark
- Share
- Report
- prev
- next
Biography
ALLEGED FRAUD WARNING:
https://www.odishabamboo.org/admin/data/documents/latestnews_1937925146.pdf?
A report by the National Bamboo Mission (NBM) committee has highlighted significant issues with tissue culture bamboo plants supplied by private firms, including Growmore Biotech (Hosur, Tamil Nadu), Kala Biotech Pvt Ltd (Pune), and IshVed Biotech Ltd (Pune). The committee found that many of these Bambusa balcooa (Beema bamboo) saplings flowered prematurely and died, leading to substantial losses for farmers. Specifically, approximately 40% of the affected farmers had purchased plantlets from Growmore Biotech, while 20% each had sourced from Kala Biotech and IshVed Biotech. The report suggested that practices adopted in tissue culture laboratories might have contributed to this issue and advised against following the companies’ recommendations to revive the plantations, as such efforts were deemed futile and likely to increase farmers’ losses.
Dr. N. Barathi, 62, Agriculture Scientist for the past 40 years, conducted Applied research in Bamboo for 20 years to increase the yield and industrial application of bamboo Power, Bio-CNG, Bio-Petrol/Diesel, Bio-Ethanol, and cement production. “Member & Advisor” in the Bamboo Steering Committee of Gujarat, Tamil Nadu, Karnataka. Exporter of Tissue culture bamboo plants to 25 different countries for the last 20 years.
Dr. Barathi is the Founder Director of Growmore Biotech Ltd., certified by DBT-GOI and accredited by AQIS-Australia.
